Drug disarms deadly C. difficile
A drug that blocks the intestinal pathogen without killing resident, beneficial microbes may prove superior to antibiotics, currently the front-line treatment for the infection.
Drug combination fights pancreatic cancer
When used together, two drugs that affect the structure and function of DNA blocked the growth of pancreatic tumor cells in mice. Researchers hope the drugs can soon be tested in humans with pancreatic cancer.
Why binge drinking may lead to alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Committee appointed to search for next CEO of Stanford Health Care
The committee will be co-chaired by John Levin, chair of the SHC Board of Directors, and Lloyd Minor, MD, dean of the School of Medicine.
Amir Rubin to step down from SHC at year's end
During his five-year tenure, the hospital CEO has launched the construction of the new Stanford Hospital and an expansion of the organization’s primary-care and outpatient networks.
More than $500,000 for projects on pediatric cancer
The funding from the St. Baldrick’s Foundation supports research to find cures and better treatments for pediatric cancers.